CVRX
HEALTHCARECVRx Inc
$7.07-0.43 (-5.73%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CVRX Today?
No stock-specific AI insight has been generated for CVRX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.30$11.30
$7.07
Fundamentals
Market Cap$186M
P/E Ratio—
EPS$-2.04
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.9%
Debt / Equity—
Trading
Volume279K
Avg Volume (10D)—
Shares Outstanding26.3M
CVRX News
21 articles- Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded PopulationYahoo Finance·May 4, 2026
- CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock NowYahoo Finance·May 1, 2026
- CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026Yahoo Finance·Apr 27, 2026
- CVRx Announces Nomination of Michael Dale for Election to the Board of DirectorsYahoo Finance·Apr 20, 2026
- CVRx Reports Preliminary First Quarter 2026 Financial ResultsYahoo Finance·Apr 13, 2026
- CVRx, Inc. Investigated by the Portnoy Law FirmGlobeNewswire Inc.·Apr 9, 2026
- CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual MeetingYahoo Finance·Mar 2, 2026
- CVRx Inc (CVRX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amid ...Yahoo Finance·Feb 16, 2026
- Analysts Are Updating Their CVRx, Inc. (NASDAQ:CVRX) Estimates After Its Full-Year ResultsYahoo Finance·Feb 15, 2026
- CVRx, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 13, 2026
- CVRx Q4 Earnings Call HighlightsMarketbeat·Feb 12, 2026
- CVRx: Q4 Earnings SnapshotYahoo Finance·Feb 12, 2026
- CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsYahoo Finance·Feb 12, 2026
- CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026Yahoo Finance·Jan 29, 2026
- Sector Update: Health Care Stocks Softer Late AfternoonYahoo Finance·Jan 23, 2026
- CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded PopulationYahoo Finance·Jan 22, 2026
- CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 GuidanceYahoo Finance·Jan 12, 2026
- CVRx Announces Implementation of New Category I CPT Codes for Barostim TherapyYahoo Finance·Jan 6, 2026
- CVRx to Present at the 44th Annual J.P. Morgan Healthcare ConferenceYahoo Finance·Dec 22, 2025
- CVRx to Participate at the Piper Sandler 37th Annual Healthcare ConferenceYahoo Finance·Nov 19, 2025
All 21 articles loaded
Price Data
Open$7.55
Previous Close$7.50
Day High$8.06
Day Low$7.42
52 Week High$11.30
52 Week Low$4.30
52-Week Range
$4.30$11.30
$7.07
Fundamentals
Market Cap$186M
P/E Ratio—
EPS$-2.04
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.9%
Debt / Equity—
Trading
Volume279K
Avg Volume (10D)—
Shares Outstanding26.3M
About CVRx Inc
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—